Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

May 29, 2020

Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Michael Asger AndersenZitta Barrella Harboe
May 27, 2020

Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

The Journal of Experimental Medicine
Jeffrey H LinRobert H Vonderheide
May 29, 2020

Influenza-related hospitalizations due to acute lower respiratory tract infections in a tertiary care children's hospital in Turkey

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Elif Böncüoğluİlker Devrim
June 3, 2020

Geographical disparities in human papillomavirus herd protection

Cancer Medicine
Abbey B BerensonMihyun Chang
May 23, 2020

Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Lindsay ScheetzJames J Moon
May 29, 2020

Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis

Human Vaccines & Immunotherapeutics
Jun ZhaoJing Lu
May 30, 2020

Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Alexander M M EggermontAlessandro A E Testori
May 27, 2020
Open Access

Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy

Cancer Immunology, Immunotherapy : CII
Laura A VitaleTibor Keler
May 29, 2020

Ornithine-derived oligomers and dendrimers for in vitro delivery of DNA and ex vivo transfection of skin cells via saRNA

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Francesca SavianoClaudia Conte
June 2, 2020

Hizikia fusiforme extract enhances dendritic cell maturation in vitro and in vivo

Bioscience, Biotechnology, and Biochemistry
Mi Eun KimJun Sik Lee

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.


Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

© 2020 Meta ULC. All rights reserved